Learning curve of combined modality treatment in peritoneal surface disease.
about
Impact of surgical volume of centers on post-operative outcomes from cytoreductive surgery and hyperthermic intra-peritoneal chemoperfusionCytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a review of factors contributing to morbidity and mortalityCytoreductive surgery and hyperthermic intraperitoneal chemotherapy for gastric cancer and other less common disease histologies: is it time?Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in gastric cancerLooking up: Recent advances in understanding and treating peritoneal carcinomatosisMultimodal treatment approaches for peritoneal carcinosis in colorectal cancerCritical care management and intensive care unit outcomes following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.Metastatic colorectal cancer: survival comparison of hepatic resection versus cytoreductive surgery and hyperthermic intraperitoneal chemotherapyExperiences with cytoreduction surgery plus hyperthermic intraperitoneal chemotherapy in Taiwan.Anaesthesia in patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: retrospective analysis of a single centre three-year experience.Pseudomyxoma peritonei.Early and long-term postoperative management following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.Hyperthermic intraperitoneal chemotherapy for gastric and colorectal cancer in Mainland China.Gastrointestinal complications in 147 consecutive patients with peritoneal surface malignancy treated by cytoreductive surgery and perioperative intraperitoneal chemotherapy.Cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion: The University of Arizona early experience.Diagnosis and management of peritoneal metastases from ovarian cancer.Pulmonary Complications following Cytoreductive Surgery and Perioperative Chemotherapy in 147 Consecutive Patients.Rhabdomyolysis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a case report.Preoperative Preparation and Patient Selection for Cytoreductive Surgery and HIPECComplications of Cytoreductive Surgery and HIPEC in the Treatment of Peritoneal MetastasesThe role of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Ovarian Cancer: A Review.Cytoreductive Surgery plus HIPEC for Peritoneal Metastases from Colorectal CancerA phase II study evaluating the use of concurrent mitomycin C and capecitabine in patients with advanced unresectable pseudomyxoma peritoneiCytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma.Surgical biology for the clinician: peritoneal mesothelioma: current understanding and management.Mucinous adenocarcinomas with intra-abdominal dissemination: a review of current therapy.Diffuse malignant peritoneal mesothelioma: systematic review of clinical management and biological research.Treatment of gastric cancer with peritoneal carcinomatosis by cytoreductive surgery and HIPEC: a systematic review of survival, mortality, and morbidity.Management of peritoneal carcinomatosis from colorectal cancer.Cytoreductive surgery and intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis from colorectal origin.Peritoneal cancer treatment.Outcomes with cytoreductive surgery and HIPEC for peritoneal metastasis.Role of peritoneal lavage cytology and prediction of prognosis and peritoneal recurrence after curative surgery for colorectal cancer.Oligometastatic Disease in the Peritoneal Space with Gastrointestinal Cancer.The Initial Indian Experience with Cytoreductive Surgery and HIPEC in the Treatment of Peritoneal Metastases.Role of CRS and HIPEC in appendiceal and colorectal malignancies: Indian experience.Impact of peritoneal carcinomatosis in the disease history of colorectal cancer management: a longitudinal experience of 2406 patients over two decadesHepatobiliary procedures in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.Learning curve for cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis.Pharmacokinetic study of perioperative intravenous Ifosfamide.
P2860
Q26768302-58A293B3-9103-4148-BDFE-F7CFE29630FEQ26768309-EF9C667B-68BC-4DE4-8511-9D79F2286EAFQ26768312-F0C8B95F-1024-4791-ABA2-1A9547B7E500Q26774538-7681BD9C-7FDE-4D07-BF38-FE04F866FFF8Q26849259-9288473E-1AA0-49B2-97B3-AE44BCA5EC54Q26852135-6D3EBCD8-9322-4CF3-B80E-DF3E6F260467Q33634993-0BECC23D-B44F-41A2-8CAD-4B3E7E389FAFQ33850248-D89CDD2B-8446-4FF6-937C-6C72BD216A66Q33879752-10547852-CA7A-41E7-87A2-BF7587A8FA84Q33960679-52C91DE8-B39D-4066-AEB3-103A8CB41406Q34391046-91E08F5F-6B37-465E-896C-F12F5FBCE12DQ34391061-97320C52-05F1-4F40-A7CC-C70FAD703686Q34670914-370E3D91-51F4-4356-BAEA-95737E0A2397Q35687621-C6CBE23C-28BC-4C73-BC77-4F9670659C0AQ36103736-48789560-4CFB-400D-904A-094701C8DC7EQ36128985-B692E3BB-3A46-4262-A905-5598FB54C773Q36181429-BEB73B26-4014-4504-A99C-4B0BA7E46700Q36613837-3A690F35-CC4A-48F7-880C-438227124826Q36758908-8F235629-7601-42BB-878B-560CC1F427BEQ36758917-B71D27CF-FC50-46AF-9176-AEC45A746AE2Q36758929-B08F1912-AE0E-48B4-8471-150433009DFCQ36758936-BE3533E9-4BEC-459A-9D61-3BFDA4022C5DQ36858196-3191E923-D3E8-4EC8-AD33-E6AB9CF8DAFCQ37166451-16AF6137-22AA-4BB8-8328-944E550D92E1Q37398672-DD4A3F90-13D1-483B-9A39-3D8C542A14ABQ37775430-2439EA65-439E-4A3D-BB14-B3A33347E6CDQ37833952-9FD4DC4E-8983-4E41-995C-01262117F060Q37895575-469D094A-25C3-4229-ACC0-F1075D9A5D45Q37910396-CCE4AC3E-D250-4ACF-B7D1-8E07373540BBQ38112342-686959F0-648A-4477-8155-CE3AF2F3D04DQ38195114-0083CC54-496C-4D2A-9617-D31F65F39FBEQ38244051-3C49728F-DA83-4940-9E39-25B1C7C5BAF4Q38429774-908FCB7A-6A25-4343-A3A7-9B982340F6CFQ38726776-323A2298-D2D4-40FC-AFBF-C35E2CEE39E3Q38882994-11D7AB80-2E9E-4625-BB89-D881EC0E205BQ39191466-F633B1AA-F8BB-4F80-9817-E308D042C79BQ39922489-C7B7FEF9-E4BE-41E0-A04E-538283BB271DQ40344591-5D704E18-D033-42FA-8246-52B87BF84876Q40580908-0410287A-1832-466A-BDEE-CE30B49A5B74Q40583827-5BECB957-B60E-4170-A40F-92F8744CDF67
P2860
Learning curve of combined modality treatment in peritoneal surface disease.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Learning curve of combined modality treatment in peritoneal surface disease.
@en
Learning curve of combined modality treatment in peritoneal surface disease.
@nl
type
label
Learning curve of combined modality treatment in peritoneal surface disease.
@en
Learning curve of combined modality treatment in peritoneal surface disease.
@nl
prefLabel
Learning curve of combined modality treatment in peritoneal surface disease.
@en
Learning curve of combined modality treatment in peritoneal surface disease.
@nl
P2093
P356
P1476
Learning curve of combined modality treatment in peritoneal surface disease.
@en
P2093
Verwaal VJ
Zoetmulder FA
P304
P356
10.1002/BJS.5863
P407
P577
2007-11-01T00:00:00Z